TriNet Group Inc. research snapshot
TNET AI stock analysis reads TriNet Group as a Professional Employer Organization that confirmed an earnings inflection in its Q2 2026 report and raised full-year guidance. At the August 4, 2026 data cutoff, the stock closed at $70.48 on August 3, 2026, up 7.06% on the day, with a market cap near $3.24 billion, trailing P/E of about 18.9x, and forward P/E near 16.6x. The bullish case rests on improved retention, an insurance cost ratio back inside the target range, a returning sales force, and AI investments. The bear case is that WSE counts are still down 11% to 12% year over year, health cost trends remain in the high single digits, and the stock now sits above the consensus analyst target of $64.40 after a sharp rally. This page is an information tool and not investment advice.
Current price
$70.48 (August 3, 2026 close)
Market cap
$3.24 billion
AI score
70 / 100
Rating
Earnings inflection confirmed with raised guidance and improved retention, but the stock now trades above the consensus analyst target of $64.40 with RSI near 71 approaching overbought
Trend status
TNET jumped about 42% from the late June level near $49 to close at $70.48 on August 3, 2026, above both its 50-day and 200-day moving averages and just 3.6% below the 52-week high of $73.08
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | TriNet co-employs worksite employees for small and mid-size businesses, bundling payroll, tax administration, health and retirement benefits, workers compensation, and compliance. Revenue is largely insurance service revenue plus professional service fees tied to WSE counts, which makes the model recurring but dependent on US SMB employment and healthcare cost trends. | Medium-high |
| Moat | The moat comes from regulatory compliance expertise, insurance buying scale and risk-taking capacity, the operational friction of switching PEO providers, and a national broker network. It is moderate rather than wide, and the 2025 to 2026 repricing cycle showed how health cost inflation can temporarily erode retention. | Medium |
| Management | CEO Mike Simonds and CFO Mala Murthy have executed an 18-month repricing reset, brought the insurance cost ratio back to 86% inside the target range, improved retention with attrition down 36% year over year, and raised full-year earnings guidance. Capital allocation includes share repurchases and a growing dividend. | Medium-high |
| Financial trend | TTM revenue is about $4.83 billion, down about 3.3% year over year, with TTM net income of about $175 million and TTM EPS of about $3.72. Q2 2026 revenue declined 5% but GAAP EPS rose 50% to $1.15 and adjusted EPS rose 35% to $1.55, helped by the improved insurance cost ratio. Free cash flow is solid at about $288 million TTM. | Medium-high |
| Valuation | At $70.48, TNET trades at about 18.94x trailing EPS, 16.57x forward earnings on the statistics page, about 14.6x the consensus FY2026 adjusted EPS of $4.84, 11.24x trailing free cash flow, and about 9.05x EV/EBITDA. The dividend yield is 1.65%. The market prices in the guidance raise and the start of a WSE recovery. | Medium |
| Technical trend | The stock closed at $70.48 on August 3, 2026, above the 50-day moving average of $52.84 and the 200-day moving average of $50.60, and about 3.6% below the 52-week high of $73.08. RSI near 71 is approaching overbought after the sharp post-earnings rally, and the August 3 move followed an 8.15% drop on July 31. | Medium |
| Risk level | Key risks are continued WSE volume decline, health cost inflation returning above the high single digits, a weaker than expected fall selling season, competition from ADP, Insperity, Paychex, and newer entrants, the high single digit insurance cost ratio target, and elevated volatility after a 42% one-month rally. | Medium-high |
| AI confidence | Medium-high for the descriptive data including price, financials, valuation, analyst targets, WSE metrics, and the Q2 2026 results, which reconcile across StockAnalysis, Macrotrends, the earnings release, and the earnings call. Lower confidence for predicting WSE stabilization timing and second-half insurance cost ratio seasonality. | Medium-high data confidence |
| Investment certainty | Medium. The earnings inflection is real and supported by raised guidance, but the stock is no longer cheap, consensus targets sit below the current price, and the business remains cyclical. The setup rewards monitoring WSE counts, retention, health cost trends, and the fall selling season rather than a high-conviction directional call. | Medium |
TNET AI stock forecast
The TNET AI stock forecast uses scenario ranges around the $70.48 August 3, 2026 close. It does not claim AI can predict a specific price. The scenarios are anchored to the consensus analyst target of $64.40, the range of analyst targets from $50 to $82, and consensus FY2026 adjusted EPS of about $4.84 rising to about $4.89 in FY2027. The bullish case requires WSE volume to stabilize and grow with contained health costs, the base case assumes steady improvement toward guidance, and the bearish case assumes WSE decline persists or health costs accelerate.
$78 to $88
More likely if total WSE counts stabilize and turn positive, retention continues improving, insurance cost ratios hold near 86% to 88%, the fall selling season delivers the promised year-over-year sales growth, and the market re-rates earnings toward the upper end of the raised guidance. The highest analyst target is $82.
$60 to $72
More likely if WSE decline slows through the second half, retention improves as guided, insurance cost ratio follows normal second-half seasonality, and earnings track the raised guidance of $4.50 to $5.10 adjusted EPS. This keeps the stock in the zone of the $64.40 consensus target and the $62 median.
$48 to $58
More likely if WSE counts keep falling at double-digit rates, health cost trends accelerate above the high single digits, the insurance cost ratio worsens in the second half, or the sales recovery stalls, pushing earnings below guidance. JPMorgan holds a Sell rating with a $50 target.
TNET AI technical analysis
TNET AI technical analysis starts from the $70.48 August 3, 2026 close, with a 52-week range of $33.61 to $73.08. The stock rallied about 42% from the late June level near $49, breaking above the 50-day moving average near $52.84 and the 200-day moving average near $50.60. RSI near 71 and the volatility around the July 30 earnings report mean levels should be confirmed on a live chart before trading.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $70.48 | August 3, 2026 close, up 7.06% after an 8.15% drop on July 31, 2026, from the StockAnalysis daily history. |
| 52-week high | $73.08 | Set on July 30, 2026. A close above this level would confirm a new uptrend. |
| 52-week low | $33.61 | The stock has more than doubled from this level over the past year. |
| Near support | $64 to $66 | The area of the July 31 low near $64.08 and the August 3 open near $66.98. A break below would signal the rally is losing momentum. |
| Secondary support | $60 to $62 | The mid-July trading platform near $60 to $62 that served as a base before the earnings rally. |
| 50-day moving average | $52.84 | From the StockAnalysis statistics page on August 4, 2026. The price is about 33% above this level, showing how steep the rally has been. |
| 200-day moving average | $50.60 | From the StockAnalysis statistics page on August 4, 2026. Trading well above the longer-term average keeps the primary trend positive. |
| Momentum | RSI near 71 | The StockAnalysis statistics page showed RSI at 70.96 on August 4, 2026, approaching overbought after the earnings-driven surge. |
| Volume | About 395,000 shares average | The 20-day average volume is about 395,494 shares. The earnings period saw elevated volume around 665,000 to 705,000 shares. |
| Volatility | Beta 0.89, elevated daily swings | Beta is below the market average, but recent daily moves of 7% to 8% around the earnings report show event-driven volatility that position sizing should account for. |
| Invalidation | Close below $64, then $60 | A close below the $64 to $66 support zone weakens the post-earnings setup. A move below $60 would suggest the rally has failed and WSE concerns dominate again. |
TNET AI trading strategy
The TNET AI trading strategy is a rules-based framework, not personalized advice. It combines the filing-backed business evidence from the Q2 2026 report, technical confirmation around the moving averages and the $73.08 high, position sizing for the elevated post-earnings volatility, and monitoring of WSE counts, retention, health cost trends, and the fall selling season.
A sustained close above the $73.08 52-week high on above-average volume would confirm the uptrend and open the path toward the analyst high target of $82. The 50-day moving average near $52.84 and the $64 to $66 zone are the first trend filters to hold.
A close back below the $64 to $66 support zone, especially on elevated volume, would reduce confidence in the trend-following setup given the steepness of the rally.
If TNET pulls back toward the $64 to $66 zone or the $60 to $62 platform with declining volume, compare the setup against WSE trends, retention commentary, health cost data, and the raised FY2026 guidance before acting. The 1.65% dividend provides a small income cushion during drawdowns.
Do not assume the pullback is a buying opportunity solely because the trailing P/E near 19x looks reasonable. WSE counts are still declining year over year, so a value trap remains possible if volume deterioration persists.
Track quarterly total WSE counts and year-over-year changes, retention and attrition metrics, the insurance cost ratio against the 87% to 90% long-term range, professional service revenue, sales force and broker channel growth, buyback activity, and management commentary on health cost trends and the fall selling season.
Reduce confidence if total WSE decline accelerates, the insurance cost ratio worsens in the second half as utilization and deductibles reset, or FY2026 guidance is revised down after the raise on July 30, 2026.
Investment research summary
TriNet co-employs workers for small and mid-size businesses, handling payroll, benefits, workers compensation, and regulatory compliance while clients keep daily operational control. Clients pay through insurance service revenue and professional service fees, and the economics are driven by WSE counts, retention, and the insurance cost ratio.
The moat is moderate and rests on regulatory compliance expertise, national insurance buying scale, the friction of switching PEO providers, and a growing broker channel. It is more service-intensive than technology-protected, and the repricing cycle of 2025 to 2026 showed that health cost inflation can temporarily weaken retention.
The thesis fails if US employment weakness keeps driving WSE counts down, health cost inflation accelerates above the high single digits and pushes the insurance cost ratio back up, the sales recovery stalls after the Q2 sales flat print, or competitors such as ADP, Insperity, and Paychex take share. The 7% decline on July 31, 2026 shows how quickly sentiment can reverse.
CEO Mike Simonds and CFO Mala Murthy executed the repricing reset that brought the insurance cost ratio back to 86%, improved retention with attrition down 36% year over year, expanded the sales force through the Ascend program, acquired and integrated Cocoon for leave administration, and raised full-year guidance on July 30, 2026.
PEO adoption remains under-penetrated among US SMBs, and roughly 90% of SMBs that buy healthcare do so through insurance brokers, which is why the broker channel with RFP growth of 54% year over year matters. Health cost trends are stable in the high single digits but remain a persistent input to pricing.
At $70.48 with a $3.24 billion market cap, TNET trades at about 18.94x trailing EPS, about 16.6x forward earnings, and 11.24x trailing free cash flow. The consensus analyst target of $64.40 is below the current price, so the margin of safety has narrowed after the rally and now depends on WSE stabilization and continued margin execution.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| TNET price | $70.48 close on August 3, 2026, up 7.06% | StockAnalysis TNET daily history | August 4, 2026 |
| Market capitalization | $3.24 billion on StockAnalysis, verified as $70.48 times 45.90 million shares with a 0.15% deviation using financial_rigor.py; Macrotrends shows about $3.02 billion on a slightly different share basis | StockAnalysis statistics, financial_rigor.py, Macrotrends | August 4, 2026 |
| TTM revenue | About $4.83 billion on the StockAnalysis statistics page, with the financials page showing TTM revenue of $4.884 billion and FY2025 revenue of $5.01 billion versus about $4.94 billion on the overview page | StockAnalysis statistics and financials | August 4, 2026 |
| TTM net income | $175 million on the StockAnalysis statistics page, with $142 million reported for the first half of 2026 in the Q2 2026 earnings release | StockAnalysis statistics and TriNet Q2 2026 earnings release | July 30, 2026 |
| EPS (TTM) | $3.72 (StockAnalysis statistics) | StockAnalysis statistics | August 4, 2026 |
| Q2 2026 results | Total revenues $1.178 billion, down 5% year over year; professional service revenues $159 million, down 8%; GAAP net income $53 million and diluted EPS $1.15, up 50%; adjusted net income $72 million and adjusted EPS $1.55, up 35%; adjusted EBITDA $128 million at a 10.9% margin; insurance cost ratio 86% | TriNet Q2 2026 earnings release | July 30, 2026 |
| FY2026 guidance | Total revenues $4.75 billion to $4.9 billion; professional service revenues raised to $647 million to $663 million; insurance cost ratio improved to 89.5% to 88.5%; adjusted EBITDA margin raised to 8.5% to 9%; GAAP EPS $2.85 to $3.35; adjusted EPS raised to $4.50 to $5.10 | TriNet Q2 2026 earnings release | July 30, 2026 |
| Worksite employees | Average WSEs 297,615 in Q2 2026, down 11% year over year; total WSEs 299,655, down 12%; approximately 274,000 co-employed WSEs on the earnings call, down 11% | TriNet Q2 2026 earnings release and earnings call | July 30, 2026 |
| Free cash flow (TTM) | $288 million on StockAnalysis; Q2 2026 free cash flow of $67 million, up 18% year over year | StockAnalysis statistics and TriNet Q2 2026 earnings release | August 4, 2026 |
| Cash and debt | Cash and cash equivalents $358 million on the balance sheet as of June 30, 2026, long-term debt $896 million, total assets $3.346 billion, total stockholders equity $125 million | TriNet Q2 2026 Form 10-Q | July 30, 2026 |
| 52-week price range | $33.61 to $73.08 | StockAnalysis statistics | August 4, 2026 |
| Valuation math | 18.94x TTM PE, 16.57x forward PE, 11.24x trailing P/FCF, 0.67x PS, 9.05x EV/EBITDA, 1.65% dividend yield, verified with financial_rigor.py | StockAnalysis statistics and financial_rigor.py | August 4, 2026 |
| Analyst consensus | 7 analysts, Hold rating, average price target $64.40, median $62, range $50 to $82; JPMorgan Sell at $50, TD Cowen Hold at $66, Truist Hold at $62 | StockAnalysis forecast | July 31, 2026 |
| Moving averages and RSI | 50-day moving average $52.84, 200-day moving average $50.60, RSI 70.96, 20-day average volume 395,494 shares, short interest 1.43 million shares at 3.12% of shares outstanding | StockAnalysis statistics | August 4, 2026 |
| Dividend | $1.16 per share annualized at a 1.65% yield, quarterly payout of $0.29 with ex-dividend date July 1, 2026, payout ratio 31.17% | StockAnalysis dividend page | July 1, 2026 |
This TNET AI stock analysis is an informational tool for research and education only. It is not investment advice, a recommendation, or a guarantee of future performance. Forecast ranges are scenarios based on available data as of August 4, 2026 and can be wrong if US employment conditions, WSE counts, healthcare cost trends, insurance cost ratios, sales results, or competitive dynamics change. TriNet is a cyclical PEO business whose results are sensitive to the employment cycle and health insurance costs.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
